Metabolic disturbances and inflammatory dysfunction predict severity of coronavirus disease 2019 (COVID-19): a retrospective study
2020 · medRxiv · 91 citations
https://doi.org/10.1101/2020.03.24.20042283
K
Kang Zhao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
608
Citations
7
h-index
7
i10-index
Kang Zhao is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & COVID-19 Clinical Research Studies & Coronary Interventions and Diagnostics. The author has an h-index of 7, co-authored 24 publications.
ORCID: 0000-0002-6199-7428Papers by this author
worksMechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking
2020 · Chinese Medicine · 62 citations
https://doi.org/10.1186/s13020-020-00346-6
Chronic remote ischemic conditioning treatment in patients with chronic stable angina (EARLY-MYO-CSA): a randomized, controlled proof-of-concept trial
2023 · BMC Medicine · 5 citations
https://doi.org/10.1186/s12916-023-03041-z
Corrigendum to “The “ <i>L</i> ‐Sandwich” Strategy for True Coronary Bifurcation Lesions: A Randomized Clinical Trial”
2025 · Journal of Interventional Cardiology · 0 citations
https://doi.org/10.1155/joic/9764137
P024: Updated efficacy and safety of SHR-A1811, an anti-HER2 antibodydrug conjugate, in heavily pretreated advanced solid tumors with HER2-expression or mutations: a global, multicenter, phase 1 study
2025 · The Breast · 0 citations
https://doi.org/10.1016/j.breast.2025.103912
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat